Hextar Healthcare Bhd

Hextar Healthcare Bhd exhibits a capital structure with a low debt-to-equity ratio of 0.01, indicating minimal leverage and a strong equity base. The company's liquidity position is characterized by a current ratio of 5.82, suggesting robust short-term liquidity. However, the company's free cash flow is negative at -36.18 million MYR, which may signal potential challenges in sustaining operations without external financing. Profitability metrics for Hextar Healthcare Bhd are concerning, with a return on equity of -9.84% and a return on assets of -9.31%. These figures are below the industry median for Medical Equipment, Supplies & Distribution, indicating underperformance relative to peers. The company's operating income is negative at -35.46 million MYR, and net income is also negative at -44.50 million MYR, reflecting operational inefficiencies and cost overruns. The company's revenue is distributed across three segments: Gloves Operation, Medical Devices Operation, and Property Investment. The Gloves Operation is the primary revenue driver, with a focus on household and industrial gloves. The Medical Devices Operation includes the production of IVD rapid test kits and ELISA kits. The Property Investment segment is less prominent but contributes to the company's diversified revenue streams. Growth trajectory for Hextar Healthcare Bhd is uncertain, with a negative net income and declining profitability. The company's capital expenditure of -6.51 million MYR suggests a reduction in investment in new projects or capacity expansion. The outlook for the current fiscal year indicates a need for operational improvements to reverse the negative financial trends. Risk factors for Hextar Healthcare Bhd include liquidity concerns, as the company has negative net cash after subtracting total debt. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's recent financial performance and negative cash flows may necessitate additional financing, which could lead to dilution of existing shareholders. Recent events and filings for Hextar Healthcare Bhd highlight the company's focus on the export market and its diversified product portfolio. The company's involvement in the production of IVD medical devices and nitrile disposable gloves positions it in a growing sector, but the current financial performance suggests challenges in capitalizing on these opportunities.